News and Events
| Monday, 28 March 2011 16:09 |
|
We strongly believe that careful selection and evaluation of investigators is critical for successful enrollment and study conduct. That is why we created a solid database of potential investigators and implemented a proprietary system to evaluate their performance at the end of each study. We have excellent personal contacts with a number of opinion leaders and scientific experts who are willing to act as principal investigators and members of the scientific advisory boards for our clinical trials. Our well-established relationships in Russian and Ukrainian medical communities give us direct access to key scientists and patients at the major medical centers. Our key advantages in the process of site selection:
|
News and messages from CEO,
Dr Vladimir Bogin
05.01.2012 |
Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012. [...] |
14.12.2011 |
Cromos Pharma published a white paper with review of Russian clinical trials market in 2011. [...] |
28.10.2011 |
Cromos Pharma's CEO, Dr. Vladimir Bogin has participated in the annual Rusnanotech forum in Moscow, Russia on 25-28 October 2011 . [...] |
27.09.2011 |
Meet us at 17th Annual International Partnering Conference BIO-Europe 2011 in Duesseldorf, Germany on 31 October - 02 November 2011. [...] |
31.08.2011 |
Moscow office of Cromos Pharma has moved to a new facility. [...] |


